Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biology Open|November 22, 2016
Calcium homeostasis alterations in a mouse model of the Dynamin 2-related centronuclear myopathyBodvaël Fraysse, Pascale Guicheney, Marc Bitoun
Annals of Neurology|June 27, 2009
Oxidative stress in SEPN1-related myopathy: from pathophysiology to treatmentSandrine Arbogast, Maud Beuvin, Bodvaël Fraysse, et al.
American Journal of Physiology. Cell Physiology|July 2, 2010
Ca2+ overload and mitochondrial permeability transition pore activation in living delta-sarcoglycan-deficient cardiomyocytesBodvaël Fraysse, Sadia M Nagi, Belinda Boher, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 19, 2003
Decrease in resting calcium and calcium entry associated with slow-to-fast transition in unloaded rat soleus muscleBodvaël Fraysse, Jean-François Desaphy, Sabata Pierno, et al.
Endocrinology|July 10, 2013
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/nonpeptidyl structureAntonella Liantonio, Gianluca Gramegna, Giuseppe Carbonara, et al.
BMC Musculoskeletal Disorders|April 14, 2017
Gait characterization in golden retriever muscular dystrophy dogs using linear discriminant analysisBodvaël Fraysse, Inès Barthélémy, El Mostafa Qannari, et al.
Traffic (Copenhagen, Denmark)|February 29, 2012
A centronuclear myopathy--dynamin 2 mutation impairs autophagy in miceAnne-Cécile Durieux, Stéphane Vassilopoulos, Jeanne Lainé, et al.
Journal of Molecular and Cellular Cardiology|April 3, 2012
Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in miceBodvaël Fraysse, Florian Weinberger, Sonya C Bardswell, et al.
Human Molecular Genetics|September 23, 2010
A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in miceAnne-Cécile Durieux, Alban Vignaud, Bernard Prudhon, et al.
Journal of Translational Medicine|December 21, 2021
TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMDAnna Creisméas, Claire Gazaille, Audrey Bourdon, et al.
Pageof 2